Alterome Therapeutics, Inc

Alterome Therapeutics is a San Diego-based biopharmaceutical company focused on developing next-generation, small molecule targeted therapies for the treatment of cancer. They utilize a structure-guided drug discovery approach, employing their in-house computational chemistry platform, “The Kraken,” to design alteration-specific therapies that precisely target high-value, validated oncogenic drivers. Their mission is to discover precise therapies and inspire hope for individuals affected by cancer. Alterome has a strong commitment to their employees and their San Diego community, evidenced by their recognition as a “Best Place to Work” and their support of Life Science Cares.

Alterome is dedicated to fighting cancer for the long haul, inspiring hope for a lifetime, and extending the lives of patients. They are pursuing this goal by developing a pipeline of precision, small molecule therapies that target a broad spectrum of validated oncogenic targets. They have a unique blend of expertise in computational and quantum chemistry, medicinal chemistry, and translational biology, enabling them to develop mutation and isoform-selective inhibitors against validated oncogenes. With their strong leadership, committed team, and innovative approach, Alterome is poised to make a significant impact on the fight against cancer.

Alterome Therapeutics does not explicitly state any details regarding job flexibility on their website or in their job postings.

Alterome Therapeutics offers a competitive benefits package to its employees, including comprehensive medical, dental, and vision insurance with several options to choose from, as well as supplemental coverage options. They also provide a 401(k) plan with a 4% employer match, encouraging employees to save for retirement. Alterome is committed to employee growth and development, offering opportunities for collaboration, training, mentorship, and continuous learning.

Alterome Therapeutics is a biopharmaceutical company dedicated to discovering precise therapies that target specific genetic alterations driving cancer growth, offering hope to patients with limited treatment options. They are driven by their core values of accountability, creativity, perseverance, longevity, compassion, and co-elevation, and leverage their in-house computational chemistry platform, "The Kraken," to develop next-generation, small molecule targeted therapies. Alterome's mission is to transform the lives of cancer patients by providing durable and safe treatments that attack difficult-to-treat cancers, ultimately inspiring hope for a lifetime.

Alterome Therapeutics promotes a collaborative and results-oriented culture that values accountability, creativity, perseverance, and compassion. They emphasize the importance of teamwork and co-elevation, encouraging employees to share their voices and contribute to the company's mission of discovering life-changing therapies for cancer patients. The company fosters a supportive environment with a focus on personal growth and development, highlighted by their investment in employee training and mentorship programs. This dedication to employee well-being is further exemplified by their commitment to community involvement and providing competitive benefits packages.

Alterome Therapeutics is committed to building a diverse and inclusive organization. They believe in measuring each applicant, candidate, and employee based on their qualifications for the role, regardless of protected class characteristics. They are also dedicated to achieving all business objectives in compliance with all federal, state, and local laws, further demonstrating their commitment to diversity, equity, and inclusion.